Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Dyslipidemia

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 64 articles: HTML format

Single Articles

April 2024
1. WRIGHT RS, Leiter LA, Lesogor A, Ray KK, et al
   Reply: Evaluation of the Inclisiran Safety in High-Risk Populations.
   J Am Coll Cardiol. 2024;83:e129.
   PubMed    
   
   
   
2. JIANG X, Zhang Z, Ding H
   Evaluation of the Inclisiran Safety in High-Risk Populations.
   J Am Coll Cardiol. 2024;83:e127.
   PubMed    
   
   
   March 2024
3. SZAREK M, Bhatt DL, Miller M, Brinton EA, et al
   Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.
   J Am Coll Cardiol. 2024 Mar 15:S0735-1097(24)00384.
   PubMed     Abstract available
   
   
   
4. BLAHA MJ, Bhatia HS
   Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy.
   J Am Coll Cardiol. 2024 Mar 9:S0735-1097(24)00944.
   PubMed    
   
   
   December 2023
5. BALLANTYNE CM, Minhas AMK, Orringer CE
   Inclisiran: Where Are We on Safety, Efficacy, and Clinical Effectiveness of siRNA Therapies for Prevention?
   J Am Coll Cardiol. 2023;82:2262-2264.
   PubMed    
   
   
   
6. WRIGHT RS, Koenig W, Landmesser U, Leiter LA, et al
   Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials.
   J Am Coll Cardiol. 2023;82:2251-2261.
   PubMed     Abstract available
   
   
   October 2023
7. GIDDING SS
   Childhood Screening for Familial Hypercholesterolemia: JACC Review Topic of the Week.
   J Am Coll Cardiol. 2023;82:1558-1563.
   PubMed     Abstract available
   
   
   August 2023
8. BEN-YEHUDA O
   Combination Therapy With Lower Statin Dose and the Race to LDL-C Goal: A Clear Winner?
   J Am Coll Cardiol. 2023;82:411-413.
   PubMed    
   
   
   
9. LEE SJ, Joo JH, Park S, Kim C, et al
   Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention.
   J Am Coll Cardiol. 2023;82:401-410.
   PubMed     Abstract available
   
   
   July 2023
10. KALRA DK, Vorla M, Michos ED, Agarwala A, et al
    Dyslipidemia in Human Immunodeficiency Virus Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:171-181.
    PubMed     Abstract available
    
    
    
11. MORALES J, Handelsman Y
    Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:161-170.
    PubMed     Abstract available
    
    
    May 2023
12. KAZI DS, DeJong C, Chen R, Wadhera RK, et al
    The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;81:2103-2111.
    PubMed     Abstract available
    
    
    April 2023
13. CHOI D, Malick WA, Koenig W, Rader DJ, et al
    Familial Hypercholesterolemia: Challenges for a High-Risk Population: JACC Focus Seminar 1/3.
    J Am Coll Cardiol. 2023;81:1621-1632.
    PubMed     Abstract available
    
    
    
14. BALLANTYNE CM, Banka P, Mendez G, Garcia R, et al
    Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616.
    J Am Coll Cardiol. 2023;81:1553-1564.
    PubMed     Abstract available
    
    
    January 2023
15. JIMENEZ A, Vinals C, Marco-Benedi V, Gonzalez P, et al
    Sex Disparities in Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2023;81:203-205.
    PubMed    
    
    
    
16. BALLING M, Afzal S, Davey Smith G, Varbo A, et al
    Elevated LDL Triglycerides and Atherosclerotic Risk.
    J Am Coll Cardiol. 2023;81:136-152.
    PubMed     Abstract available
    
    
    
17. MAKI KC, Dicklin MR
    Caution Against Rejecting All Dietary Supplements for LDL Cholesterol Reduction.
    J Am Coll Cardiol. 2023;81:13-15.
    PubMed    
    
    
    November 2022
18. HEDEGAARD BS, Bork CS, Kaltoft M, Klausen IC, et al
    Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
    J Am Coll Cardiol. 2022;80:1998-2010.
    PubMed     Abstract available
    
    
    August 2022
19. LLOYD-JONES DM, Morris PB, Ballantyne CM, Birtcher KK, et al
    2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committe
    J Am Coll Cardiol. 2022 Aug 23. pii: S0735-1097(22)05594.
    PubMed    
    
    
    
20. MOHEBI R, Chen C, Ibrahim NE, McCarthy CP, et al
    Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
    J Am Coll Cardiol. 2022;80:565-578.
    PubMed     Abstract available
    
    
    June 2022
21. DOI T, Langsted A, Nordestgaard BG
    Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction.
    J Am Coll Cardiol. 2022;79:2383-2397.
    PubMed     Abstract available
    
    
    
22. HAUGE MG, Damm P, Kofoed KF, Ersboll AS, et al
    Early Coronary Atherosclerosis in Women With Previous Preeclampsia.
    J Am Coll Cardiol. 2022;79:2310-2321.
    PubMed     Abstract available
    
    
    May 2022
23. STUART JJ, Tanz LJ, Rimm EB, Spiegelman D, et al
    Cardiovascular Risk Factors Mediate the Long-Term Maternal Risk Associated With Hypertensive Disorders of Pregnancy.
    J Am Coll Cardiol. 2022;79:1901-1913.
    PubMed     Abstract available
    
    
    
24. GABA P, Bhatt DL, Steg PG, Miller M, et al
    Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
    J Am Coll Cardiol. 2022;79:1660-1671.
    PubMed     Abstract available
    
    
    March 2022
25. HOVINGH GK, Klausen IC, Heggen E, McCarty K, et al
    Resmetirom (MGL-3196) in Patients With Heterozygous Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2022;79:1220-1222.
    PubMed    
    
    
    
26. SNIDERMAN AD, Glavinovic T, Thanassoulis G
    Key Questions About Familial Hypercholesterolemia: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:1023-1031.
    PubMed     Abstract available
    
    
    January 2022
27. SINGH N, Bhatt DL, Miller M, Steg PG, et al
    Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT.
    J Am Coll Cardiol. 2022;79:220-222.
    PubMed    
    
    
    November 2021
28. BRANDTS J, Ray KK
    Familial Hypercholesterolemia: JACC Focus Seminar 4/4.
    J Am Coll Cardiol. 2021;78:1831-1843.
    PubMed     Abstract available
    
    
    
29. ROSENSON RS, Shaik A, Song W
    New Therapies for Lowering Triglyceride-Rich Lipoproteins: JACC Focus Seminar 3/4.
    J Am Coll Cardiol. 2021;78:1817-1830.
    PubMed     Abstract available
    
    
    October 2021
30. TALASAZ AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, et al
    Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1635-1654.
    PubMed     Abstract available
    
    
    
31. DZAYE O, Razavi AC, Dardari ZA, Shaw LJ, et al
    Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults.
    J Am Coll Cardiol. 2021;78:1573-1583.
    PubMed     Abstract available
    
    
    
32. GABA P, Bhatt DL, Giugliano RP, Steg PG, et al
    Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
    J Am Coll Cardiol. 2021;78:1525-1537.
    PubMed     Abstract available
    
    
    
33. OLEAGA C, Shapiro MD, Hay J, Mueller PA, et al
    Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory Antibodies.
    J Am Coll Cardiol. 2021;78:1437-1449.
    PubMed     Abstract available
    
    
    August 2021
34. VIRANI SS, Morris PB, Agarwala A, Ballantyne CM, et al
    2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2021;78:960-993.
    PubMed    
    
    
    July 2021
35. AHMAD Z, Pordy R, Rader DJ, Gaudet D, et al
    Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia.
    J Am Coll Cardiol. 2021;78:193-195.
    PubMed    
    
    
    June 2021
36. RAPOSEIRAS-ROUBIN S, Rossello X, Oliva B, Fernandez-Friera L, et al
    Triglycerides and Residual Atherosclerotic Risk.
    J Am Coll Cardiol. 2021;77:3031-3041.
    PubMed     Abstract available
    
    
    
37. LOPEZ-SAINZ A, Mila L, Rodriguez-Palomares J, Limeres J, et al
    Aortic Branch Aneurysms and Vascular Risk in Patients With Marfan Syndrome.
    J Am Coll Cardiol. 2021;77:3005-3012.
    PubMed     Abstract available
    
    
    
38. SABATINE MS, Braunwald E
    Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8.
    J Am Coll Cardiol. 2021;77:2822-2845.
    PubMed     Abstract available
    
    
    March 2021
39. TSIMIKAS S, Moriarty PM, Stroes ES
    Emerging RNA Therapeutics to Lower Blood Levels of Lp(a): JACC Focus Seminar 2/4.
    J Am Coll Cardiol. 2021;77:1576-1589.
    PubMed     Abstract available
    
    
    
40. NURMOHAMED NS, Navar AM, Kastelein JJP
    New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4.
    J Am Coll Cardiol. 2021;77:1564-1575.
    PubMed     Abstract available
    
    
    
41. JOHANNESEN CDL, Mortensen MB, Langsted A, Nordestgaard BG, et al
    Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.
    J Am Coll Cardiol. 2021;77:1439-1450.
    PubMed     Abstract available
    
    
    
42. WRIGHT RS, Ray KK, Raal FJ, Kallend DG, et al
    Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis.
    J Am Coll Cardiol. 2021;77:1182-1193.
    PubMed     Abstract available
    
    
    February 2021
43. PERAKAKIS N, Farr OM, Mantzoros CS
    Leptin in Leanness and Obesity: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:745-760.
    PubMed     Abstract available
    
    
    
44. CICERO AFG, Fogacci F, Zambon A
    Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar.
    J Am Coll Cardiol. 2021;77:620-628.
    PubMed     Abstract available
    
    
    January 2021
45. PIETRI P, Stefanadis C
    Cardiovascular Aging and Longevity: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:189-204.
    PubMed     Abstract available
    
    
    December 2020
46. GHOSHHAJRA BB, Foldyna B, Gaudet D, Khoury E, et al
    Coronary Atheroma Regression From Infusions of Autologous Selectively Delipidated Prebeta-HDL-Enriched Plasma in Homozygous Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;76:3062-3064.
    PubMed    
    
    
    
47. CASTANER O, Pinto X, Subirana I, Amor AJ, et al
    Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    J Am Coll Cardiol. 2020;76:2712-2724.
    PubMed     Abstract available
    
    
    
48. KRISHNASWAMI A, Beavers C, Dorsch MP, Dodson JA, et al
    Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;76:2650-2670.
    PubMed     Abstract available
    
    
    November 2020
49. BHATT DL, Budoff MJ, Mason RP
    A Revolution in Omega-3 Fatty Acid Research.
    J Am Coll Cardiol. 2020;76:2098-2101.
    PubMed    
    
    
    October 2020
50. MECHANICK JI, Rosenson RS, Pinney SP, Mancini DM, et al
    Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;76:2024-2035.
    PubMed     Abstract available
    
    
    September 2020
51. BOCCARA F, Rosenson RS
    Reply: Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.
    J Am Coll Cardiol. 2020;76:1503-1504.
    PubMed    
    
    
    
52. SINGH A, Mittal S, Kazimuddin M
    Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.
    J Am Coll Cardiol. 2020;76:1503.
    PubMed    
    
    
    
53. ROSENSON RS, Colantonio LD, Goonewardena SN
    Optimizing Cholesterol Management Improves the Benefits of Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2020;76:1451-1454.
    PubMed    
    
    
    July 2020
54. THOMPSON GR
    PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia: Useful But Seldom Sufficient.
    J Am Coll Cardiol. 2020;76:143-145.
    PubMed    
    
    
    
55. BLOM DJ, Harada-Shiba M, Rubba P, Gaudet D, et al
    Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia: The ODYSSEY HoFH Trial.
    J Am Coll Cardiol. 2020;76:131-142.
    PubMed     Abstract available
    
    
    June 2020
56. TOTH PP
    Familial Hypercholesterolemia and Lipoprotein(a): Unraveling the Knot That Binds Them.
    J Am Coll Cardiol. 2020;75:2694-2697.
    PubMed    
    
    
    
57. TRINDER M, DeCastro ML, Azizi H, Cermakova L, et al
    Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia.
    J Am Coll Cardiol. 2020;75:2682-2693.
    PubMed     Abstract available
    
    
    May 2020
58. KASTELEIN JJP, Reeskamp LF, Hovingh GK
    Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans.
    J Am Coll Cardiol. 2020;75:2567-2569.
    PubMed    
    
    
    
59. BEHESHTI SO, Madsen CM, Varbo A, Nordestgaard BG, et al
    Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
    J Am Coll Cardiol. 2020;75:2553-2566.
    PubMed     Abstract available
    
    
    
60. BOCCARA F, Kumar PN, Caramelli B, Calmy A, et al
    Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.
    J Am Coll Cardiol. 2020;75:2570-2584.
    PubMed     Abstract available
    
    
    
61. BHATT DL, Briggs AH, Reed SD, Annemans L, et al
    Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial.
    J Am Coll Cardiol. 2020;75:2297-2308.
    PubMed     Abstract available
    
    
    
62. DURAN EK, Aday AW, Cook NR, Buring JE, et al
    Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    J Am Coll Cardiol. 2020;75:2122-2135.
    PubMed     Abstract available
    
    
    April 2020
63. DIENER HC, Hankey GJ
    Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;75:1804-1818.
    PubMed     Abstract available
    
    
    
64. LOPEZ-MELGAR B, Fernandez-Friera L, Oliva B, Garcia-Ruiz JM, et al
    Short-Term Progression of Multiterritorial Subclinical Atherosclerosis.
    J Am Coll Cardiol. 2020;75:1617-1627.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.